These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25029134)

  • 1. Sepsis and pharmacogenomics: can the VAS(S)T majority of vasopressor treatment be individualized?*.
    Westphal M; van Haren FM
    Crit Care Med; 2014 Aug; 42(8):1944-5. PubMed ID: 25029134
    [No Abstract]   [Full Text] [Related]  

  • 2. Serious adverse events associated with vasopressin and norepinephrine infusion in septic shock.
    Anantasit N; Boyd JH; Walley KR; Russell JA
    Crit Care Med; 2014 Aug; 42(8):1812-20. PubMed ID: 24919159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is vasopressin increasing or decreasing mortality in patients with septic shock?
    Rehberg S; Ertmer C; Van Aken H; Westphal M
    Surg Infect (Larchmt); 2008 Apr; 9(2):215 author reply 216. PubMed ID: 18426355
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
    Haan BJ; Cadiz ML; Natavio AM
    Ann Pharmacother; 2020 Mar; 54(3):213-218. PubMed ID: 31625395
    [No Abstract]   [Full Text] [Related]  

  • 5. Vasopressin in septic shock.
    Russell JA
    Crit Care Med; 2007 Sep; 35(9 Suppl):S609-15. PubMed ID: 17713417
    [No Abstract]   [Full Text] [Related]  

  • 6. Vasopressin for vasopressor-dependent septic shock.
    Szumita PM; Enfanto CM; Greenwood B; Wechsler ME
    Am J Health Syst Pharm; 2005 Sep; 62(18):1931-6. PubMed ID: 16141113
    [No Abstract]   [Full Text] [Related]  

  • 7. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
    Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
    Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
    Patel GP; Grahe JS; Sperry M; Singla S; Elpern E; Lateef O; Balk RA
    Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock.
    Wu JY; Stollings JL; Wheeler AP; Semler MW; Rice TW
    Ann Pharmacother; 2017 Jan; 51(1):13-20. PubMed ID: 27630192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis.
    Stolk RF; van der Poll T; Angus DC; van der Hoeven JG; Pickkers P; Kox M
    Am J Respir Crit Care Med; 2016 Sep; 194(5):550-8. PubMed ID: 27398737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of vasopressin and the vasopressin type V1a receptor agonist selepressin in septic shock.
    Saad AF; Maybauer MO
    J Crit Care; 2017 Aug; 40():41-45. PubMed ID: 28319910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin: A tool as rescue therapy? Take care of dosages and adverse effects!
    Angstwurm M
    Crit Care Med; 2005 Nov; 33(11):2713-4. PubMed ID: 16276218
    [No Abstract]   [Full Text] [Related]  

  • 13. Exogenous Vasopressin-Induced Hyponatremia in Patients With Vasodilatory Shock: Two Case Reports and Literature Review.
    Salazar M; Hu BB; Vazquez J; Wintz RL; Varon J
    J Intensive Care Med; 2015 Jul; 30(5):253-8. PubMed ID: 24106070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the Addition of Vasopressin to Catecholamine Vasopressors Affect Outcomes in Patients With Distributive Shock?
    Roumpf SK; Hunter BR
    Ann Emerg Med; 2019 Jul; 74(1):153-155. PubMed ID: 30446352
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vasopressin for treatment of hemodynamic disorders].
    Adukauskiene D; Sirvinskas E; Kevelaitis E
    Medicina (Kaunas); 2008; 44(2):167-73. PubMed ID: 18344670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressor-Sparing Action of Methylene Blue in Severe Sepsis and Shock: A Narrative Review.
    Puntillo F; Giglio M; Pasqualucci A; Brienza N; Paladini A; Varrassi G
    Adv Ther; 2020 Sep; 37(9):3692-3706. PubMed ID: 32705530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral administration of vasopressin for catecholamine-resistant hypotension complicated by skin necrosis.
    Bunker N; Higgins D
    Crit Care Med; 2006 Mar; 34(3):935; author reply 935-6. PubMed ID: 16505698
    [No Abstract]   [Full Text] [Related]  

  • 18. Is the addition of vasopressin to norepinephrine beneficial for the treatment of septic shock?
    Sandifer JP; Jones AE
    Ann Emerg Med; 2013 Nov; 62(5):534-535. PubMed ID: 23683544
    [No Abstract]   [Full Text] [Related]  

  • 19. Norepinephrine Dysregulates the Immune Response and Compromises Host Defense during Sepsis.
    Stolk RF; van der Pasch E; Naumann F; Schouwstra J; Bressers S; van Herwaarden AE; Gerretsen J; Schambergen R; Ruth MM; van der Hoeven JG; van Leeuwen H; Pickkers P; Kox M
    Am J Respir Crit Care Med; 2020 Sep; 202(6):830-842. PubMed ID: 32520577
    [No Abstract]   [Full Text] [Related]  

  • 20. Vasopressin in septic shock.
    Landry DW; Oliver JA
    N Engl J Med; 2008 Jun; 358(25):2736-7; author reply 2737-8. PubMed ID: 18572443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.